bariatric surgery glp 1 vs Metabolic and versus glucagon-like peptide-1 receptor agonist therapy: A comparison of cardiovascular outcomes in patients with obesity Bariatric surgery is less expensive – Metabolic bariatric surgery in face

No confirmed evidence from published studies demonstrates that BPC-157 causes cancer, though its angiogenic mechanism creates a theoretical risk of accelerating growth in pre-existing tumors through increased vascular supply

The improvement activities ASM performance category incentivizes care coordination and collaboration between specialty medicine and primary care, creating new opportunities for both groups playing vital roles in care management and coordination

Annals of Internal Medicine DOI:10.7326/ANNALS-25-00860 Abstract Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy: A Target Trial Emulation Background: There are few data evaluating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and nonarteritic anterior ischemic optic neuropathy (NAION), which constitutes approximately 75% of ischemic optic neuropathy (ION) cases in adults

The rationale is that GLP-1 agonists can reduce B12 absorption over time, and supplementing directly in the injection addresses this proactively

However, the chronic use of ibuprofen at high doses is associated with increased risk for cardiovascular, renal, gastrointestinal and liver injuries